---

---

symbols : Nvsef    crawled time : 18:00   

save search

---

New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Published: 2024-04-15 (Crawled : 18:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| Email alert Add to watchlist
fabhalta nephropathy for novartis show

---

Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | $92.9 -2.18% 880 |

Health Technology

| 0.3% | O: 2.24% H: 0.0% C: -0.8%
AZNCF | $138.88 -4.19% 960 |

Health Technology

| 2.04% | O: -3.43% H: 6.21% C: 6.21%
VTRS | $11.32 -0.09% -0.09% 4.4M |

Health Technology

| -4.07% | O: -0.25% H: 1.1% C: -0.17%
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| -1.44% | O: -0.05% H: 0.43% C: -0.27%
BMY | $48.51 0.48% 0.0% 12M |

Health Technology

| -5.48% | O: -0.08% H: 0.04% C: -0.35%
BHC | $8.63 -1.48% 0.0% 3.2M |

Health Technology

| -17.1% | O: 0.38% H: 0.0% C: -7.27%
ABBV | $161.67 -0.38% -0.04% 5.4M |

Health Technology

| -3.72% | O: 0.77% H: 1.63% C: 0.35%
SNY | $46.22 0.63% 0.63% 1.7M |

Health Technology

| -0.12% | O: 0.84% H: 0.0% C: 0.0%
AZN | $68.75 -0.26% -0.26% 7.6M |

Health Technology

| 1.9% | O: 0.18% H: 0.3% C: 0.19%
eczema dermatitis set therapeutics market

---

Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
BMY | $48.51 0.48% 0.0% 12M |

Health Technology

| Email alert Add to watchlist
GILD | $67.76 -1.3% -1.31% 7.7M |

Health Technology

| Email alert Add to watchlist
SNYNF | $92.9 -2.18% 880 |

Health Technology

| Email alert Add to watchlist
AMGN | $265.505 -0.66% -0.67% 1.7M |

Health Technology

| Email alert Add to watchlist
GMAB | $29.51 0.85% 0.85% 500K |

Health Technology

| Email alert Add to watchlist
SNY | $46.22 0.63% 0.63% 1.7M |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| Email alert Add to watchlist
GNMSF | $291.12 3.83% 300 |

Health Technology

| Email alert Add to watchlist
ABBV | $161.67 -0.38% -0.04% 5.4M |

Health Technology

| Email alert Add to watchlist
research global leukemia therapeutics market

---

United States Pharmaceuticals Market Size to Surpass US$ 1,068.02 Billion by 2030 | Exhibiting a CAGR of 8.6% Says CoherentMI
Published: 2024-02-22 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -8.97% | O: 0.37% H: 0.58% C: 0.58%
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| -8.16% | O: 0.89% H: 0.4% C: 0.17%
LLY | $750.77 -0.12% 0.0% 2.3M |

Health Technology

| -2.45% | O: 0.57% H: 0.47% C: -0.58%
BMY | $48.51 0.48% 0.0% 12M |

Health Technology

| -5.49% | O: 0.14% H: 1.01% C: 0.51%
ABBV | $161.67 -0.38% -0.04% 5.4M |

Health Technology

| -8.53% | O: 0.29% H: 0.93% C: 0.47%
SNY | $46.22 0.63% 0.63% 1.7M |

Health Technology

| -2.18% | O: 0.97% H: 0.0% C: 0.0%
GILD | $67.76 -1.3% -1.31% 7.7M |

Health Technology

| -6.91% | O: 0.65% H: 1.35% C: 0.41%
AMGN | $265.505 -0.66% -0.67% 1.7M |

Health Technology

| -6.9% | O: 0.47% H: 2.0% C: 0.93%
pharmaceuticals market

---

Vertigo Drugs Market Research Report 2023 - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2018-2028F
Published: 2024-02-01 (Crawled : 18:00) - prnewswire.com
ENDPQ 6 d | $0.0003 -50.0% 24K |

n/a

| 200.0% | O: -83.33% H: 500.0% C: 500.0%
GLAXF | $20.07 -14.18% 1K |

Health Technology

| 1.0% | O: -0.7% H: 0.0% C: 0.0%
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| -10.37% | O: -0.5% H: 0.26% C: -1.03%
GSK | $40.5 -0.39% -0.03% 2.8M |

Health Technology

| -0.32% | O: -0.05% H: 0.59% C: 0.27%
report research global market

---

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.07 -14.18% 1K |

Health Technology

| 4.69% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | $138.88 -4.19% 960 |

Health Technology

| 3.57% | O: 3.41% H: 0.0% C: -2.45%
VTRS | $11.32 -0.09% -0.09% 4.4M |

Health Technology

| -4.15% | O: -0.08% H: 3.47% C: -0.25%
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| -12.38% | O: -2.04% H: 0.19% C: -1.97%
GSK | $40.5 -0.39% -0.03% 2.8M |

Health Technology

| 3.61% | O: 4.04% H: 1.57% C: -3.02%
ABBV | $161.67 -0.38% -0.04% 5.4M |

Health Technology

| -1.97% | O: 0.5% H: 0.07% C: -0.81%
SNY | $46.22 0.63% 0.63% 1.7M |

Health Technology

| -6.76% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $5.35 1.52% 1.5% 270K |

Health Technology

| 12.28% | O: -0.1% H: 2.31% C: -1.26%
AZN | $68.75 -0.26% -0.26% 7.6M |

Health Technology

| 2.28% | O: 0.82% H: 0.12% C: -1.64%
AMGN | $265.505 -0.66% -0.67% 1.7M |

Health Technology

| -15.61% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

---

Kidney Transplantation Therapeutics Market 2023; USD 643.15 million Growth Expected between 2023 and 2028, Rising prevalence of CKD and renal impairments to boost growth - Technavio
Published: 2024-01-29 (Crawled : 18:00) - prnewswire.com
ALPMF | $9.48 43.47% 1.7K |

Health Technology

| -16.48% | O: 1.76% H: 0.0% C: 0.0%
GLAXF | $20.07 -14.18% 1K |

Health Technology

| 6.51% | O: 2.93% H: 0.0% C: -1.15%
ALPMY | $9.55 -1.11% 300K |

Manufacturing

| -20.07% | O: -3.53% H: 3.49% C: 3.4%
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| -12.54% | O: -0.59% H: 0.49% C: 0.41%
GSK | $40.5 -0.39% -0.03% 2.8M |

Health Technology

| 3.69% | O: 0.26% H: 0.13% C: -0.18%
ABBV | $161.67 -0.38% -0.04% 5.4M |

Health Technology

| -1.37% | O: 0.19% H: 0.46% C: 0.43%
SNY | $46.22 0.63% 0.63% 1.7M |

Health Technology

| -6.65% | O: 0.12% H: 0.0% C: 0.0%
kidney renal expected million therapeutics growth market

---

Global Transdermal Skin Patches Market Forecast Report, 2024-2030: A $9.9B Projected Industry, Dominated by Teva Pharma, 3M Company, Nitto Denko Corporation, and Johnson & Johnson
Published: 2024-01-19 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -12.65% | O: -0.19% H: 0.0% C: 0.0%
VTRS | $11.32 -0.09% -0.09% 4.4M |

Health Technology

| 0.44% | O: 0.0% H: 1.42% C: 1.15%
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| -12.61% | O: -0.44% H: 0.64% C: 0.63%
JNJ | $147.59 0.05% 0.0% 8.5M |

Health Technology

| -7.72% | O: 0.67% H: 0.0% C: 0.0%
ABT | $108.89 -0.2% 0.04% 4.6M |

Health Technology

| -4.65% | O: -0.24% H: 0.0% C: 0.0%
MMM | $91.3 -0.01% 0.31% 3.5M |

Producer Manufacturing

| -14.22% | O: 0.28% H: 1.52% C: 0.96%
transdermal global teva skin market

---

2023 Inhalers Pipeline Research Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Published: 2024-01-17 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -12.65% | O: 0.0% H: 0.0% C: 0.0%
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| -12.79% | O: -0.78% H: 0.59% C: 0.57%
VRNA | $15.82 -0.57% -0.57% 320K |

Health Technology

| -8.35% | O: 0.52% H: 2.31% C: -0.87%
NKTR | $1.56 -6.59% -7.05% 2.8M |

Health Technology

| 218.07% | O: -0.73% H: 12.24% C: 12.24%
companies report pipeline research key

---

Narcolepsy Drugs Market, Size, Global Forecast 2024-2030: Daytime Sleepiness Crucial to the Narcolepsy Drugs Market, Sodium Oxybate Dominates
Published: 2023-12-29 (Crawled : 18:00) - prnewswire.com
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
narcolepsy global

---

Global Melanoma Treatment Market Report 2023, Featuring Comprehensive Profiles of Leading Players including Amgen, Roche, Merck & Co., Pfizer Inc., BMS and Novartis
Published: 2023-12-13 (Crawled : 18:00) - prnewswire.com
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| -5.32% | O: -1.67% H: 1.17% C: 0.85%
ARMK | $31.47 -0.38% 0.0% 2.9M |

Consumer Services

| 15.91% | O: 0.88% H: 1.88% C: 0.69%
melanoma report merck treatment global novartis market

---

Rheumatoid Arthritis Drugs Market to grow by USD 16.04 billion from 2023 to 2028; North America to account for 39% of market growth- Technavio
Published: 2023-12-04 (Crawled : 18:00) - prnewswire.com
ALPMF | $9.48 43.47% 1.7K |

Health Technology

| -19.52% | O: 0.26% H: 0.0% C: 0.0%
GLAXF | $20.07 -14.18% 1K |

Health Technology

| 9.78% | O: -2.6% H: 1.1% C: -1.18%
SNYNF | $92.9 -2.18% 880 |

Health Technology

| -0.99% | O: 0.27% H: 0.12% C: 0.12%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -4.4% | O: -1.1% H: 0.0% C: 0.0%
ALPMY | $9.55 -1.11% 300K |

Manufacturing

| -23.38% | O: 0.0% H: 0.5% C: 0.17%
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| -4.63% | O: -1.86% H: 0.34% C: -0.19%
GSK | $40.5 -0.39% -0.03% 2.8M |

Health Technology

| 10.57% | O: -1.01% H: 0.39% C: 0.19%
ABBV | $161.67 -0.38% -0.04% 5.4M |

Health Technology

| 12.75% | O: 0.51% H: 0.68% C: 0.32%
SNY | $46.22 0.63% 0.63% 1.7M |

Health Technology

| 0.18% | O: -0.5% H: 0.0% C: 0.0%
GLMD | $0.378 -9.79% -10.85% 88K |

Health Technology

| -3.54% | O: 0.03% H: 2.44% C: -1.03%
AMGN | $265.505 -0.66% -0.67% 1.7M |

Health Technology

| -2.58% | O: -0.25% H: 0.05% C: -0.37%
america market

---

Anti-CD20 Monoclonal Antibodies (mABs) Market size to grow by USD 11.42 billion from 2023 to 2028; North America to account for 57% of market growth- Technavio
Published: 2023-11-09 (Crawled : 18:00) - prnewswire.com
AZNCF | $138.88 -4.19% 960 |

Health Technology

| 7.15% | O: 0.1% H: 0.0% C: -2.14%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -0.86% | O: -2.87% H: 0.0% C: 0.0%
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| 1.27% | O: 0.32% H: 0.14% C: 0.01%
AZN | $68.75 -0.26% -0.26% 7.6M |

Health Technology

| 7.24% | O: -1.33% H: 0.22% C: -0.11%
AMGN | $265.505 -0.66% -0.67% 1.7M |

Health Technology

| 0.55% | O: 0.98% H: 0.49% C: 0.25%
cd20 america market

---

Incyte to Spotlight More Than 40 Hematology and Oncology Abstracts Including a Plenary Presentation at the ASH Annual Meeting
Published: 2023-11-02 (Crawled : 18:00) - biospace.com/
TAK | $13.18 -1.42% 0.0% 1.8M |

Health Technology

| -3.44% | O: 1.03% H: 0.73% C: 0.58%
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| 0.16% | O: -1.09% H: 1.03% C: 0.91%
XNCR | $20.09 -1.9% -1.94% 390K |

Health Technology

| 15.11% | O: 1.32% H: 0.45% C: -1.19%
MOR | $18.02 -0.22% -0.22% 640K |

Health Technology

| 121.92% | O: 2.22% H: 0.6% C: -9.4%
INCY | $53.42 -0.8% -0.8% 1.6M |

Health Technology

| -1.73% | O: -0.28% H: 1.0% C: -0.46%
presentation meeting

---

Cell Therapy Market to grow by USD 31.04 billion from 2022 to 2027 | Proven effectiveness of CAR T-cell therapy boosts the market - Technavio
Published: 2023-10-04 (Crawled : 18:00) - prnewswire.com
LSTA | $2.8999 -5.82% 3.3K |

Manufacturing

| 36.71% | O: 3.86% H: 0.93% C: -2.33%
ALPMY | $9.55 -1.11% 300K |

Manufacturing

| -31.37% | O: 0.59% H: 0.29% C: 0.22%
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| -1.87% | O: -1.21% H: 1.3% C: 1.16%
BCLI | $0.54 -7.53% -8.15% 570K |

Health Technology

| 188.79% | O: -0.37% H: 10.94% C: -4.38%
t-cell cell therapy market

---

Global Chimeric Antigen Receptor T (CAR-T) Cells Market 2023: Industry Analysis Report Examines the $2.76 Billion Market
Published: 2023-06-29 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 13.52% | O: 1.03% H: 0.0% C: -4.47%
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| -4.98% | O: 0.74% H: 0.81% C: 0.81%
BMY | $48.51 0.48% 0.0% 12M |

Health Technology

| -24.2% | O: 0.44% H: 0.2% C: -0.51%
AUTL | $4.9 -2.39% -2.45% 790K |

Health Technology

| 114.91% | O: 1.75% H: 3.97% C: 2.59%
report global market

---

Global Gaucher's Disease Treatment Market Research Report 2023: Emerging Therapies, Clinical Trials, Treatments, Current Scenario Evaluation, Patient Profile
Published: 2023-05-10 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 8.88% | O: 0.92% H: 0.0% C: 0.0%
TAK | $13.18 -1.42% 0.0% 1.8M |

Health Technology

| -22.38% | O: -1.83% H: 0.12% C: -3.06%
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| -8.9% | O: -0.4% H: 0.34% C: 0.19%
JNJ | $147.59 0.05% 0.0% 8.5M |

Health Technology

| -8.7% | O: 0.11% H: 0.22% C: -0.52%
ABT | $108.89 -0.2% 0.04% 4.6M |

Health Technology

| -1.63% | O: -0.57% H: 0.37% C: -0.01%
SNY | $46.22 0.63% 0.63% 1.7M |

Health Technology

| -13.36% | O: -0.28% H: 0.0% C: 0.0%
disease report treatment research global market

---

Open-angle glaucoma therapeutics market size to grow by USD 2.58 billion from 2021 to 2026; AbbVie Inc. and Aerie Pharmaceuticals Inc, among others, emerge as key vendors - Technavio
Published: 2023-04-12 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 16.68% | O: 1.25% H: 0.51% C: 0.51%
VTRS | $11.32 -0.09% -0.09% 4.4M |

Health Technology

| 15.27% | O: 0.31% H: 1.42% C: 0.71%
TARO | $42.12 0.19% 0.0% 17K |

Health Technology

| 71.29% | O: -1.14% H: 3.54% C: 2.34%
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| -2.14% | O: 1.3% H: 0.56% C: 0.51%
ALC | $81.09 -0.23% 0.0% 690K |

Health Technology

| 14.97% | O: 1.5% H: 0.77% C: 0.6%
ABBV | $161.67 -0.38% -0.04% 5.4M |

Health Technology

| -0.42% | O: -0.84% H: 1.16% C: 1.05%
glaucoma abbvie pharmaceuticals therapeutics market

---

Global Generic Pharmaceuticals Market Report 2023: Major Players Include Teva Pharmaceuticals, Mylan NV, Sandoz International, Hospira and Sun Pharmaceutical
Published: 2023-03-15 (Crawled : 18:00) - prnewswire.com
ENDPQ 6 d | $0.0003 -50.0% 24K |

n/a

| -97.74% | O: -4.14% H: 7.45% C: 4.58%
SNYNF | $92.9 -2.18% 880 |

Health Technology

| -1.74% | O: 0.0% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 37.7% | O: 2.62% H: 0.0% C: -3.57%
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| 15.01% | O: -1.0% H: 1.39% C: 1.02%
JNJ | $147.59 0.05% 0.0% 8.5M |

Health Technology

| -4.11% | O: -0.7% H: 1.34% C: 0.99%
SNY | $46.22 0.63% 0.63% 1.7M |

Health Technology

| -0.99% | O: -0.49% H: 0.0% C: 0.0%
report pharmaceuticals global teva market

---

Antiglaucoma Drugs Global Market Report 2023
Published: 2023-02-20 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
NVS | $94.41 0.95% 0.0% 1.4M |

Health Technology

| Email alert Add to watchlist
AERI | $15.25 0.0% |

Health Technology

| Email alert Add to watchlist
PFE A | $25.91 0.19% -0.04% 34M |

Health Technology

| Email alert Add to watchlist
JNJ | $147.59 0.05% 0.0% 8.5M |

Health Technology

| Email alert Add to watchlist
global report market

---

Gainers vs Losers

49%

51%

Top 10 Gainers

KAVL | $6.275 135.02% 57.45% 44M |

Wholesale Trade

PXMD | $0.7375 79.09% 44.16% 4.5M |

Health Technology

DYNT | $0.371 -5.12% 43.09% 3.3M |

Health Technology

LGVN P 3 d | $2.94 73.96% 42.52% 57M |

HUBC | $1.94 49.23% 32.99% 73M |

n/a

SPCB | $0.4044 46.52% 31.75% 130M |

Electronic Technology

ONVO | $1.34 32.66% 24.62% 54M |

Health Technology

OMQS | $0.6869 32.1% 24.3% 3.6M |

Professional, Scientific, and T...

SNPO | $10.555 29.67% 22.88% 4M |

AMBI | $3.72 -26.77% 21.77% 9.8K |

n/a

---

Your saved searches

---